The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants.
Based on titration microcalorimetry and Caco-2 cell line transfection studies, it has been suggested that the A54T of the FABP2 gene plays a significant role in the assimilation of dietary fatty acids. However, reports were divergent with regard to the in vivo interaction between this polymorphism and postprandial lipemia. We therefore determined the influence of this intestinal fatty acid-binding protein polymorphism on intestinal fat transport using the human jejunal organ culture model, thus avoiding the interference of various circulating factors capable of metabolizing in vivo postprandial lipids. Analysis of DNA samples from 32 fetal intestines revealed 22 homozygotes for the wild-type Ala-54/Ala-54 genotype (0.83) and 10 heterozygotes for the polymorphic Thr-54/Ala-54 genotype (0.17). The Thr-encoding allele was associated with increased secretion of newly esterified triglycerides, augmented de novo apolipoprotein B synthesis, and elevated chylomicron output. On the other hand, no alterations were found in very low density lipoprotein and high density lipoprotein production, apolipoprotein A-I biogenesis, or microsomal triglyceride transfer protein mass and activity. Similarly, the alanine to threonine substitution at residue 54 did not result in changes in brush border hydrolytic activities (sucrase, glucoamylase, lactase, and alkaline phosphatase) or in glucose uptake or oxidation. Our data clearly document that the A54T polymorphism of FABP2 specifically influences small intestinal lipid absorption without modifying glucose uptake or metabolism. It is proposed that, in the absence of confounding factors such as environmental and genetic variables, the FABP2 polymorphism has an important effect on postprandial lipids in vivo, potentially influencing plasma levels of lipids and atherogenesis.
Levy
E
E
Department of Nutrition, Université de Montréal, Quebec H3T 1C5, Canada. levye@justine.umontreal.ca
Ménard
D
D
Delvin
E
E
Stan
S
S
Mitchell
G
G
Lambert
M
M
Ziv
E
E
Feoli-Fonseca
J C
JC
Seidman
E
E
D000042:Absorption; D000409:Alanine / Q000235:genetics; D016632:Apolipoprotein A-I / Q000096:biosynthesis; D001055:Apolipoproteins B / Q000096:biosynthesis; D002352:Carrier Proteins / Q000235:genetics* / Q000378:metabolism; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D007583:Jejunum / Q000196:embryology / Q000378:metabolism*; D008871:Microvilli / Q000201:enzymology; D009363:Neoplasm Proteins; D019301:Oleic Acid / Q000493:pharmacokinetics*; D009924:Organ Culture Techniques; D020641:Polymorphism, Single Nucleotide; D013912:Threonine / Q000235:genetics; D014280:Triglycerides / Q000378:metabolism; D025521:Tumor Suppressor Proteins
D016632:Apolipoprotein A-I; D001055:Apolipoproteins B; D002352:Carrier Proteins; C493404:FABP2 protein, human; C107608:FABP7 protein, human; C493405:Fabp2 protein, mouse; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D009363:Neoplasm Proteins; D014280:Triglycerides; D025521:Tumor Suppressor Proteins; C106092:microsomal triglyceride transfer protein; D019301:Oleic Acid; D013912:Threonine; D000409:Alanine